Regeneron Pharmaceuticals Inc (REGN)
701.85
-6.40
(-0.90%)
USD |
NASDAQ |
Dec 20, 16:00
707.00
+5.15
(+0.73%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Quarterly): 29.33B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Eli Lilly and Co | 14.24B |
| Pfizer Inc | 92.29B |
| Biogen Inc | 16.36B |
| AbbVie Inc | 6.032B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.44B |
| Total Liabilities (Quarterly) | 8.116B |
| Debt to Equity Ratio | 0.0677 |
| Current Ratio | 5.281 |
| Net Debt Paydown Yield | -0.00% |